Take a look at our previous reports:

The future of CAR-T at point-of-care

We believe that real differentiation and access to therapy can come from a disruptive decentralized CAR-T manufacturing model at point-of-care, close to patients, combined with innovative science and expert teams.

Scroll for more

At Galapagos, our aim is to transform patient outcomes through life-changing science and innovation for more years of life and quality of life. That’s how we are #LivingInnovation.